Cancer Antigen (CA) 19-9, Serum
Familial Adenomatous Polyposis (APC) Gene Mutation Analysis
Pseudocyst of pancreas
Cholangitis
Solid Tumor Gene Mutation Panel, NGS (Oncotype MAP™, Guardant360® CDx, Guardant Reveal™, PGDx elio™, Northstar Select®, oncoReveal™, LiquidHALLMARK®, PredicineATLAS™, PGDx elio™ Assay)
Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis
MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
Acute myeloid leukemia (AML)
Colon Cancer Multi-Gene Panel, NGS (ColoNext®, COLONSEQ, COLONSEQPlus)
Dihydropyrimidine Dehydrogenase (DPYD) Genotyping
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
Medical Test
Methodology
Access to
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
is restricted.
Sign up now
Loading...